Research Management Group (RMG)

DoD Congressionally Directed Medical Research Programs

 

 

dod Breast cancer research program

 

Reissued RFP

 

Breast Cancer Research Program
Breakthrough Award Levels 1 and 2
The intent of the Breakthrough Award is to support promising research that has high potential to lead to or make breakthroughs in breast cancer.
PI and Partnering PI Eligibility:  Stanford faculty with PI eligibility (UTL, MCL, NTLR appts) and CE faculty (with an approved CE faculty waiver request >> obtained through their RPM at least 1 week prior to the pre-application/letter of intent) 
(Note: Instructors and senior postdocs cannot be partnering PIs.)
Other eligible positions: Instructors* and Senior Postdoctoral Fellows* [who do not meet the eligibility requirements of the new “Breakthrough Fellowship Award” (see below) may be considered] are eligible. [*Instructors and Senior Postdoctoral fellows must submit and obtain approval for a Career Development PI waiver request >> through their RPMs in RMG at least 1 week prior to submitting a pre-application/letter of intent.]  Per page 7 of the RFP: a mentoring statment is required.
No citizenship restriction. 
Not eligible: Clinical Instructors, and academic staff-research (i.e, research associates) are not eligible (per confirmation in previous years by Dr. Greenberg & Dr. Arvin).
Amount of funding and funding level descriptions:
Funding level 1:
Funding level 1-single PI: maximum of $375,000 direct costs plus indirects over 3 years
Funding level 1 with Partnering PI Option: combined for the two PIs: maximum of $600,000 direct costs plus indirects over 3 years
Description: Innovative, high-risk/high-reward research that is in the earliest stages of idea development. Research with potential to yield new avenues of investigation. Proof of concept. No preliminary data required. 
Funding level 2:
Funding level 2-single PI: maximum of $750,000 direct costs plus indirects over 3 years.
Funding level 2 with Partnering PI Option: combined for the two PIs: maximum of $1 million direct costs plus indirects over years
Research that is already supported by preliminary data and has potential to make significant advancements toward clinical translation. 
Timeline:
Pre-application/letter of intent (required) deadline: Nov. 1, 2018, 5 p.m. ET via https://ebrap.org/
Institutional representative (RPM/RMG or CGO/OSR) complete by date: Nov. 8, 2018
Full proposal: Nov. 15, 2018, 11:59 p.m. ET via grantsgov
Guidelines:
http://cdmrp.army.mil/funding/bcrp.shtml

 

 

 



dod duchenne Muscular dystrophy research program

 

 

 

 

DoD Duchenne Muscular Dystrophy Research Program
Career Development Award

Amount of funding: up to a maximum of $275,000 direct costs (plus indirects) for up to 2 years
Purpose: supports early-career investigators in conducting impactful Duchenne research under the mentorship of an experienced muscular dystrophy researcher as an opportunity to obtain the funding, mentoring, and experience necessary for productive, independent careers at the forefront of Duchenne research. Applicants should also demonstrate that the proposed research has high potential to lead to or make breakthroughs in Duchenne. All applications for the FY18 DMDRP funding opportunities must address at least one of the Focus Areas listed in the guidelines.
Eligibility: independent*-Stanford Assist, prof. with PI eligibility and CE assist. prof. (with an approved CE Faculty PI waiver >>).
The PI must be an independent*, early-career research- or physician-scientist with a Ph.D., M.D., or equivalent at least 2 years post-terminal degree at the time of application submission (excluding time spent in residency or on family medical leave), and exhibit a strong desire to pursue a career in Duchenne research. Physician-scientists must have clinical duties and/or responsibilities.
Institutional commitment to the PI’s independent career should be demonstrated, including a confirmation of the laboratory space, and at least 30% of protected time for Duchenne research. No citizenship restriction
Mentor: The Mentor must be an experienced muscular dystrophy researcher as demonstrated by a strong record of funding and publications in muscular dystrophy research. The Mentor must hold a position at or above the level of an Associate Professor (or equivalent).
*Not eligible: Instructors, Clinical Instructors, Academic staff-researchers (i.e., basic scientists, research associates)  are not eligible because Stanford does not consider them to be faculty level or independent positions.
Timeline:
Pre-application/Letter of intent (required) deadline:  Nov. 14, 2018, 5 p.m. ET via https://ebrap.org/
Institutional representative (RPM/RMG or OSR) deadline: Nov. 28, 2018
Full proposal deadline:  Dec. 5, 2018, 11:59 p.m. ET via grantsgov
Guidelines:
http://cdmrp.army.mil/funding/dmdrp

 

 

 

 


Institutional representatives (RMG & OSR) contact information


Institutional Representatives:
School of Medicine PIs:

PIs*: you do not have to submit your pre-application through your institutional representative.
*Exception: CE faculty must submit and obtain approval for a CE faculty PI waiver >> through their RPM in RMG >> prior to the pre-application submission.
Research Process Manager (RPM) department assignments >>
RMG internal proposal deadline policy, FAQs and best practices** webpage

For PIs in Other Schools:

Office of Sponsored Research (OSR) Contract and Grant Officer (CGO) department assignments;
Download the Pre-award assignment list from this DoResearch Office webpage >>

 


proposal intake form (PIF) in sera

 

Proposal Intake Form (PIF) in SeRA is now required for all proposal submissions in the School of Medicine (excludes Fellowships and Clinical Trials)
https://sera.stanford.edu/

PIs are encouraged to initiate a PIF in SeRA asap and at least one month prior to the sponsor's deadline.


DoResearch SeRA User Guide (Proposal routing) resources webpage:

 

 


Top

Footer Links: